Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trial
Daniel J. Lovell(Cincinnati Children's Hospital Medical Center), Rayfel Schneider(Hospital for Sick Children), Norman T. Ilowite(Schneider Children's Hospital), M. Lange(IDEX Corporation (United States)), Judyann C. Olson(Medical College of Wisconsin), Abraham Gedalia(Children's Hospital of New Orleans), Barbara Finck(Coherus BioSciences (United States)), Edward H. Giannini(Cincinnati Children's Hospital Medical Center), Carol A. Wallace(Cincinnati Children's Hospital Medical Center), Leonard D. Stein(University of North Carolina at Chapel Hill), Andreas Reiff(University of Southern California), Daniel Burge
Cited by 256
Related Papers
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
|The Lancet|2000|1.5k
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
|Arthritis & Rheumatism|2002|733